[시장보고서]연구용 항체 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 특이성별, 기술별, 공급원별, 용도별, 최종 용도별, 지역별), 부문별 예측(2025-2033년)

연구용 항체 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 특이성별, 기술별, 공급원별, 용도별, 최종 용도별, 지역별), 부문별 예측(2025-2033년)

Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1842406

리서치사 : Grand View Research

발행일 : 2025년 09월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,782,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,258,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,211,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

연구용 항체 시장 요약

세계의 연구용 항체 시장 규모는 2024년에 17억 9,000만 달러로 평가되었고, 2033년에는 39억 1,000만 달러에 이를 것으로 예측되며, 2025-2033년 연평균 복합 성장률(CAGR)은 9.15%를 보일 것으로 예측됩니다.

연구용 항체 시장은 감염 및 만성질환 유병률 증가, 단백질체학 및 유전체학 연구 개선, 맞춤형 의료의 확산 등으로 빠르게 성장하고 있습니다.

기술별 대시보드
연구용 항체 시장 : 변동 분석, 기술별
연구용 항체 시장 규모와 동향 분석 : 기술별(2021-2033년)
면역조직화학
- 면역조직화학 시장(2021-2033년)
면역 형광법
- 면역 형광 시장(2021-2033년)
웨스턴 블로팅
- 웨스턴 블로팅 시장(2021-2033년)
유세포분석기
- 유세포분석기 시장(2021-2033년)
면역 침강
- 면역 침강 시장(2021-2033년)
ELISA
- ELISA 시장(2021-2033년)
기타
- 기타 기술 시장(2021-2033년)

제7장 공급원별 비즈니스 분석

공급원별 대시보드
연구용 항체 시장 : 변동 분석, 공급원별
연구용 항체 시장 규모와 동향 분석 : 공급원별(2021-2033년)
쥐
- 쥐 시장(2021-2033년)
토끼
- 토끼 시장(2021-2033년)
염소
- 염소 시장(2021-2033년)
기타
- 기타 공급원 시장(2021-2033년)

제8장 용도별 비즈니스 분석

용도별 대시보드
연구용 항체 시장 : 변동 분석, 용도별
연구용 항체 시장 규모와 동향 분석 : 용도별(2021-2033년)
감염증
- 감염증 시장(2021-2033년)
면역질환
- 면역질환 시장(2021-2033년)
종양
- 종양 시장(2021-2033년)
줄기세포
- 줄기세포 시장(2021-2033년)
신경 생물학
- 신경 생물학 시장(2021-2033년)
기타
- 기타 용도 시장(2021-2033년)

제9장 최종 용도별 비즈니스 분석

최종 용도별 대시보드
연구용 항체 시장 : 변동 분석, 최종 용도별
연구용 항체 시장 규모와 동향 분석 : 최종 용도별(2021-2033년)
학술기관 및 연구기관
- 학술기관 및 연구기관 시장(2021-2033년)
CRO(의약품 임상시험수탁기관)
- CRO 시장(2021-2033년)
제약 기업 및 바이오테크놀러지 기업
- 제약 기업 및 바이오테크놀러지 기업 시장(2021-2033년)

제10장 지역별 비즈니스 분석

연구용 항체 시장 점유율 : 지역별(2024년, 2033년)
북미
- 북미 연구용 항체 시장(2021-2033년)
- 미국
- 캐나다
- 멕시코
유럽
- 유럽 연구용 항체 시장(2021-2033년)
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 아시아태평양 연구용 항체 시장(2021-2033년)
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 싱가포르
라틴아메리카
- 라틴아메리카 연구용 항체 시장(2021-2033년)
- 브라질
- 아르헨티나
중동 및 아프리카
- 중동 및 아프리카 연구용 항체 시장(2021-2033년)
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제11장 경쟁 구도

기업 분류
전략 매핑
기업 시장 현황 분석(2024년)
기업 개요/상장기업
- Abcam Plc
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Cell Signaling Technology, Inc.
- Santa Cruz Biotechnology Inc.
- PerkinElmer, Inc.
- Becton, Dickinson and Company
- Bio-Techne Corporation
- Proteintech Group, Inc.
- Jackson ImmunoResearch Inc

LSH

영문 목차

영문목차

Research Antibodies Market Summary

The global research antibodies market size was estimated at USD 1.79 billion in 2024 and is projected to reach USD 3.91 billion by 2033, growing at a CAGR of 9.15% from 2025 to 2033. The market for research antibodies is expanding rapidly due to the rising incidence of infectious and chronic illnesses, improvements in proteomics and genomics research, and the growing use of personalized medicine.

Global Research Antibodies Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global research antibodies market report based on product, specificity, technology, source, application, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Primary Antibodies
Secondary Antibodies
Specificity Outlook (Revenue, USD Million, 2021 - 2033)
Monoclonal Antibodies
Polyclonal Antibodies
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Immunohistochemistry
Immunofluorescence
Western Blotting
Flow Cytometry
Immunoprecipitation
ELISA
Others
Source Outlook (Revenue, USD Million, 2021 - 2033)
Mouse
Rabbit
Goat
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Infectious Diseases
Immunology
Oncology
Stem Cells
Neurobiology
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Academic & Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Singapore
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product Segment
- 1.1.2. Specificity Segment
- 1.1.3. Technology Segment
- 1.1.4. Source Segment
- 1.1.5. Application Segment
- 1.1.6. End Use Segment
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List Of Secondary Sources
1.8. List Of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Rising burden of chronic and infectious diseases
  - 3.2.1.2. Expansion of life sciences and biomedical research
- 3.2.2. Market Restraint And Challenges Analysis
  - 3.2.2.1. Uncertain government regulations
  - 3.2.2.2. Quality concerns associated with research antibodies and the time- & cost-intensive process of antibody development
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

4.1. Product Segment Dashboard
4.2. Research Antibodies Market Product Movement Analysis
4.3. Research Antibodies Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Primary Antibodies
- 4.4.1. Primary Antibodies Market, 2021 - 2033 (USD Million)
4.5. Secondary Antibodies
- 4.5.1. Secondary Antibodies Market, 2021 - 2033 (USD Million)

Chapter 5. Specificity Business Analysis

5.1. Specificity Segment Dashboard
5.2. Research Antibodies Market Specificity Movement Analysis
5.3. Research Antibodies Market Size & Trend Analysis, by Specificity, 2021 to 2033 (USD Million)
5.4. Monoclonal Antibodies
- 5.4.1. Monoclonal Antibodies Market, 2021 - 2033 (USD Million)
5.5. Polyclonal Antibodies
- 5.5.1. Polyclonal Antibodies Market, 2021 - 2033 (USD Million)

Chapter 6. Technology Business Analysis

6.1. Technology Segment Dashboard
6.2. Research Antibodies Market Technology Movement Analysis
6.3. Research Antibodies Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
6.4. Immunohistochemistry
- 6.4.1. Immunohistochemistry Market, 2021 - 2033 (USD Million)
6.5. Immunofluorescence
- 6.5.1. Immunofluorescence Market, 2021 - 2033 (USD Million)
6.6. Western Blotting
- 6.6.1. Western Blotting Market, 2021 - 2033 (USD Million)
6.7. Flow Cytometry
- 6.7.1. Flow Cytometry Market, 2021 - 2033 (USD Million)
6.8. Immunoprecipitation
- 6.8.1. Immunoprecipitation Market, 2021 - 2033 (USD Million)
6.9. ELISA
- 6.9.1. ELISA Market, 2021 - 2033 (USD Million)
6.10. Others
- 6.10.1. Other Technologies Market, 2021 - 2033 (USD Million)

Chapter 7. Source Business Analysis

7.1. Source Segment Dashboard
7.2. Research Antibodies Market Source Movement Analysis
7.3. Research Antibodies Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
7.4. Mouse
- 7.4.1. Mouse Market, 2021 - 2033 (USD Million)
7.5. Rabbit
- 7.5.1. Rabbit Market, 2021 - 2033 (USD Million)
7.6. Goat
- 7.6.1. Goat Market, 2021 - 2033 (USD Million)
7.7. Others
- 7.7.1. Other Sources Market, 2021 - 2033 (USD Million)

Chapter 8. Application Business Analysis

8.1. Application Segment Dashboard
8.2. Research Antibodies Market Application Movement Analysis
8.3. Research Antibodies Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
8.4. Infectious Diseases
- 8.4.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
8.5. Immunology
- 8.5.1. Immunology Market, 2021 - 2033 (USD Million)
8.6. Oncology
- 8.6.1. Oncology Market, 2021 - 2033 (USD Million)
8.7. Stem Cells
- 8.7.1. Stem Cells Market, 2021 - 2033 (USD Million)
8.8. Neurobiology
- 8.8.1. Neurobiology Market, 2021 - 2033 (USD Million)
8.9. Others
- 8.9.1. Other Applications Market, 2021 - 2033 (USD Million)

Chapter 9. End Use Business Analysis

9.1. End Use Segment Dashboard
9.2. Research Antibodies Market End Use Movement Analysis
9.3. Research Antibodies Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Academic & Research Institutes
- 9.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
9.5. Contract Research Organizations
- 9.5.1. Contract Research Organizations Market, 2021 - 2033 (USD Million)
9.6. Pharmaceutical & Biotechnology Companies
- 9.6.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)

Chapter 10. Regional Business Analysis

10.1. Research Antibodies Market Share By Region, 2024 & 2033
10.2. North America
- 10.2.1. North America Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.2.2. U.S.
  - 10.2.2.1. Key Country Dynamics
  - 10.2.2.2. Regulatory Framework
  - 10.2.2.3. Competitive Scenario
  - 10.2.2.4. U.S. Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.2.3. Canada
  - 10.2.3.1. Key Country Dynamics
  - 10.2.3.2. Regulatory Framework
  - 10.2.3.3. Competitive Scenario
  - 10.2.3.4. Canada Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.2.4. Mexico
  - 10.2.4.1. Key Country Dynamics
  - 10.2.4.2. Regulatory Framework
  - 10.2.4.3. Competitive Scenario
  - 10.2.4.4. Mexico Research Antibodies Market, 2021 - 2033 (USD Million)
10.3. Europe
- 10.3.1. Europe Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.3.2. UK
  - 10.3.2.1. Key Country Dynamics
  - 10.3.2.2. Regulatory Framework
  - 10.3.2.3. Competitive Scenario
  - 10.3.2.4. UK Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.3.3. Germany
  - 10.3.3.1. Key Country Dynamics
  - 10.3.3.2. Regulatory Framework
  - 10.3.3.3. Competitive Scenario
  - 10.3.3.4. Germany Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.3.4. France
  - 10.3.4.1. Key Country Dynamics
  - 10.3.4.2. Regulatory Framework
  - 10.3.4.3. Competitive Scenario
  - 10.3.4.4. France Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.3.5. Italy
  - 10.3.5.1. Key Country Dynamics
  - 10.3.5.2. Regulatory Framework
  - 10.3.5.3. Competitive Scenario
  - 10.3.5.4. Italy Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.3.6. Spain
  - 10.3.6.1. Key Country Dynamics
  - 10.3.6.2. Regulatory Framework
  - 10.3.6.3. Competitive Scenario
  - 10.3.6.4. Spain Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.3.7. Denmark
  - 10.3.7.1. Key Country Dynamics
  - 10.3.7.2. Regulatory Framework
  - 10.3.7.3. Competitive Scenario
  - 10.3.7.4. Denmark Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.3.8. Sweden
  - 10.3.8.1. Key Country Dynamics
  - 10.3.8.2. Regulatory Framework
  - 10.3.8.3. Competitive Scenario
  - 10.3.8.4. Sweden Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.3.9. Norway
  - 10.3.9.1. Key Country Dynamics
  - 10.3.9.2. Regulatory Framework
  - 10.3.9.3. Competitive Scenario
  - 10.3.9.4. Norway Research Antibodies Market, 2021 - 2033 (USD Million)
10.4. Asia Pacific
- 10.4.1. Asia Pacific Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.4.2. Japan
  - 10.4.2.1. Key Country Dynamics
  - 10.4.2.2. Regulatory Framework
  - 10.4.2.3. Competitive Scenario
  - 10.4.2.4. Japan Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.4.3. China
  - 10.4.3.1. Key Country Dynamics
  - 10.4.3.2. Regulatory Framework
  - 10.4.3.3. Competitive Scenario
  - 10.4.3.4. China Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.4.4. India
  - 10.4.4.1. Key Country Dynamics
  - 10.4.4.2. Regulatory Framework
  - 10.4.4.3. Competitive Scenario
  - 10.4.4.4. India Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.4.5. Australia
  - 10.4.5.1. Key Country Dynamics
  - 10.4.5.2. Regulatory Framework
  - 10.4.5.3. Competitive Scenario
  - 10.4.5.4. Australia Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.4.6. Thailand
  - 10.4.6.1. Key Country Dynamics
  - 10.4.6.2. Regulatory Framework
  - 10.4.6.3. Competitive Scenario
  - 10.4.6.4. Thailand Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.4.7. South Korea
  - 10.4.7.1. Key Country Dynamics
  - 10.4.7.2. Regulatory Framework
  - 10.4.7.3. Competitive Scenario
  - 10.4.7.4. South Korea Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.4.8. Singapore
  - 10.4.8.1. Key Country Dynamics
  - 10.4.8.2. Regulatory Framework
  - 10.4.8.3. Competitive Scenario
  - 10.4.8.4. Singapore Research Antibodies Market, 2021 - 2033 (USD Million)
10.5. Latin America
- 10.5.1. Latin America Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.5.2. Brazil
  - 10.5.2.1. Key Country Dynamics
  - 10.5.2.2. Regulatory Framework
  - 10.5.2.3. Competitive Scenario
  - 10.5.2.4. Brazil Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.5.3. Argentina
  - 10.5.3.1. Key Country Dynamics
  - 10.5.3.2. Regulatory Framework
  - 10.5.3.3. Competitive Scenario
  - 10.5.3.4. Argentina Research Antibodies Market, 2021 - 2033 (USD Million)
10.6. MEA
- 10.6.1. MEA Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.6.2. South Africa
  - 10.6.2.1. Key Country Dynamics
  - 10.6.2.2. Regulatory Framework
  - 10.6.2.3. Competitive Scenario
  - 10.6.2.4. South Africa Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.6.3. Saudi Arabia
  - 10.6.3.1. Key Country Dynamics
  - 10.6.3.2. Regulatory Framework
  - 10.6.3.3. Competitive Scenario
  - 10.6.3.4. Saudi Arabia Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.6.4. UAE
  - 10.6.4.1. Key Country Dynamics
  - 10.6.4.2. Regulatory Framework
  - 10.6.4.3. Competitive Scenario
  - 10.6.4.4. UAE Research Antibodies Market, 2021 - 2033 (USD Million)
- 10.6.5. Kuwait
  - 10.6.5.1. Key Country Dynamics
  - 10.6.5.2. Regulatory Framework
  - 10.6.5.3. Competitive Scenario
  - 10.6.5.4. Kuwait Research Antibodies Market, 2021 - 2033 (USD Million)

Chapter 11. Competitive Landscape

11.1. Company Categorization
11.2. Strategy Mapping
11.3. Company Market Position Analysis, 2024
11.4. Company Profiles/Listing
- 11.4.1. Abcam Plc
  - 11.4.1.1. Overview
  - 11.4.1.2. Financial Performance
  - 11.4.1.3. Product Benchmarking
  - 11.4.1.4. Strategic Initiatives
- 11.4.2. Merck KGaA
  - 11.4.2.1. Overview
  - 11.4.2.2. Financial Performance
  - 11.4.2.3. Product Benchmarking
  - 11.4.2.4. Strategic Initiatives
- 11.4.3. Thermo Fisher Scientific, Inc.
  - 11.4.3.1. Overview
  - 11.4.3.2. Financial Performance
  - 11.4.3.3. Product Benchmarking
  - 11.4.3.4. Strategic Initiatives
- 11.4.4. Cell Signaling Technology, Inc.
  - 11.4.4.1. Overview
  - 11.4.4.2. Financial Performance
  - 11.4.4.3. Product Benchmarking
  - 11.4.4.4. Strategic Initiatives
- 11.4.5. Santa Cruz Biotechnology Inc.
  - 11.4.5.1. Overview
  - 11.4.5.2. Financial Performance
  - 11.4.5.3. Product Benchmarking
  - 11.4.5.4. Strategic Initiatives
- 11.4.6. PerkinElmer, Inc.
  - 11.4.6.1. Overview
  - 11.4.6.2. Financial Performance
  - 11.4.6.3. Product Benchmarking
  - 11.4.6.4. Strategic Initiatives
- 11.4.7. Becton, Dickinson and Company
  - 11.4.7.1. Overview
  - 11.4.7.2. Financial Performance
  - 11.4.7.3. Product Benchmarking
  - 11.4.7.4. Strategic Initiatives
- 11.4.8. Bio-Techne Corporation
  - 11.4.8.1. Overview
  - 11.4.8.2. Financial Performance
  - 11.4.8.3. Product Benchmarking
  - 11.4.8.4. Strategic Initiatives
- 11.4.9. Proteintech Group, Inc.
  - 11.4.9.1. Overview
  - 11.4.9.2. Financial Performance
  - 11.4.9.3. Product Benchmarking
  - 11.4.9.4. Strategic Initiatives
- 11.4.10. Jackson ImmunoResearch Inc
  - 11.4.10.1. Overview
  - 11.4.10.2. Financial Performance
  - 11.4.10.3. Product Benchmarking
  - 11.4.10.4. Strategic Initiatives